Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;69(7):1736-1748.
doi: 10.1002/glia.23988. Epub 2021 Mar 10.

The pro-inflammatory microRNA miR-155 influences fibrillar β-Amyloid1-42 catabolism by microglia

Affiliations

The pro-inflammatory microRNA miR-155 influences fibrillar β-Amyloid1-42 catabolism by microglia

Macarena S Aloi et al. Glia. 2021 Jul.

Abstract

Microglia are the innate immune cells of the central nervous system that adopt rapid functional changes in response to Damage Associated Molecular Patterns, including aggregated β-Amyloid (Aβ) found in Alzheimer's disease (AD). microRNAs (miRNAs) are post-transcriptional modulators that influence the timing and magnitude of microglia inflammatory responses by downregulating the expression of inflammatory effectors. Recent studies implicate miR-155, a miRNA known to regulate inflammatory responses, in the pathogenesis of neurodegenerative disorders including multiple sclerosis, ALS, familial Parkinson's disease, and AD. In this work, we asked if miR-155 expression in microglia modifies cellular behaviors in response to fibrillar Aβ1-42 (fAβ1-42 ), in vitro. We hypothesized that in microglia, miR-155 expression would impact the internalization and catabolism of extracellular fAβ1-42 . Primary microglia stimulated with lipopolysaccharide demonstrate fast upregulation of miR-155 followed by delayed upregulation of miR-146a, an anti-inflammatory miRNA. Conditional overexpression of miR-155 in microglia resulted in significant upregulation of miR-146a. Conditional deletion of miR-155 promoted transit of fAβ1-42 to low-pH compartments where catabolism occurs, while miR-155 overexpression decreases fAβ1-42 catabolism. Uptake of fAβ1-42 across the plasma membrane increased with both up and downregulation of miR-155 expression. Taken together, our results support the hypothesis that inflammatory signaling influences the ability of microglia to catabolize fAβ1-42 through interconnected mechanisms modulated by miR-155. Understanding how miRNAs modulate the ability of microglia to catabolize fAβ1-42 will further elucidate the role of cellular players and molecular crosstalk in AD pathophysiology.

Keywords: catabolism; fibrillar Aβ1-42; miR-146a; miR-155; miRNAs; primary microglia.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors have no conflict of interest.

Figures

FIGURE 1
FIGURE 1. Microglia respond to LPS with phased induction of miR-155 and miR-146a in a pattern similar to macrophages.
Primary mouse neonatal microglia were plated and exposed to 100 ng/ml of LPS for one of a set of time points, then total RNA was extracted and analyzed for changes in total microRNA expression. Quantification of (a) miR-155 and (b) miR-146a expression over time post LPS exposure demonstrates that miR-155 is upregulated quickly after LPS exposure while miR-146a is delayed and appears to be upregulated after miR-155 induction. This pattern matches that seen in peripheral macrophages. (One-Way ANOVA with Bonferroni's correction for multiple comparisons. For non-treated (NT) v. miR-155: Day 1: p < .0001, Day 2: p < .0001, Day 3: p = .0016, Day 4: p = n.s. and Day 5 p = n.s. (not significant = n.s.). For miR-146a: Day 1: p = n.s., Day 2: p = n.s., Day 3: p = n.s., Day 4: p = .0441, Day 5: p = .0018. Key: *** = p < .0001, ** = p < .001
FIGURE 2
FIGURE 2. LPS influences microglia lysosomal transit of fibrillar Aβ1-42 without significantly shifting acidity of low-pH organelles.
Wild-type (WT) microglia were plated and treated with LPS (100 ng/ml) for 24 hr. Then cells were exposed to 1 μM fAβ1-42-pHrodo for 6 hr or Lysotracker Deep Red for 30 min prior to FACS analysis. (a) fAβ1-42 -pHrodo (PE) molecules localized to low-pH compartments were detected using flow cytometry (BD LSRII). The Geometric Mean of fAβ1-42 -pHrodo were calculated from biological replicates and visually appear to have lower fluorescence after exposure to LPS. (b) LPS treatment significantly downregulated transit of fAβ1-42 -pHrodo to lysosomal compartments where it would fluoresce (Unpaired t-test, p = .0039). (c) Lysotracker Deep Red (APC) representative histograms. (d) 24 hr of LPS (100 ng/ml) treatment did not significantly alter acidity of low-pH organelles (Unpaired t-test, p = .4139, n.s.). Key: ** = p < .01
FIGURE 3
FIGURE 3. LPS stimulation in primary microglia impacts intracellular handling of Aβ1-42 to low-pH compartments and at the plasma membrane.
(a) Representative images of WT microglia exposed to fAβ1-42 -pHrodo or fAβ1-42 −488 at 6 hr (where fluorophores do not colocalize) and 24 hr (where fluorophores colocalize). WT microglia were plated and treated with 100 ng/ml of LPS for 24 hr. Then, cells were treated with 1 μM of fAβ1-42 tagged with (b) pHrodo or (c) a non-pH sensitive fluorophore (488) for 6, 12, 18, and 24 hr. Total internalization and levels of fAβ1-42 located in low-pH compartments was detected using flow cytometry (BD LSRII). Geometric mean of biological replicates (n = 3) were analyzed. No change in shift to low-pH compartments was detected using fAβ1-42 -pHrodo (all n.s.). For overall internalization detected with fAβ1-42 −488 there was a significant effect of LPS treatment with increased internalization over 24 hr (Two-Way ANOVA with Tukey's Multiple Comparisons correction: Treatment: F (1,4) = 55.44, p = .0017). While the 6 hr and 24 hr timepoints appear to have particularly significant increases in internalization and the interaction of treatment by time was significant (F (3,12) = 3.577, p = .0469) the post hoc comparisons did not remain significant after multiple comparison correction
FIGURE 4
FIGURE 4. In the absence of a strong inflammatory stimulus, overexpression of miR-155 is sufficient to induce expression of miR-146a.
(a) Graphic showing workflow of conditional miR-155 overexpression (OX) in primary mouse microglia. mBIC-FSF neonatal microglia were plated and treated with rAAV2-Cre or rAAV2-Control (RFP or GFP; “Control”) for 5 days. Then total RNA was extracted and analyzed for changes in miR-155 and miR-146a expression. For (b) miR-155, OX increased in AAV-treated cells above both control and non-treated levels. One-way ANOVA, (F (2,9)=139.1, p < .0001) with Tukey's multiple comparisons. Tukey's Multiple Comparisons corrections: NT (non-treated) v. rAAV2-Cre: p < .0001; rAAV2-Control (RFP or GFP) v. rAAV2-Cre: p < .0001. (c) Without an inflammatory stimulus, but with miR-155 induction, miR-146a expression was also increased indicating that miR-155 regulates miR-146a expression in microglia. This pattern of expression is similar to peripheral macrophages. One-way ANOVA with Tukey's multiple comparisons correction; NT (non-treated) v. rAAV2-Cre: p < .0001; rAAV2-Control (RFP or GFP) v. rAAV2-Cre: p < .0001. Key: **** = p < .001
FIGURE 5
FIGURE 5. Microglia internalization and transit of fAβ1-42 to low pH compartments in the endosome/lysosome pathway is influenced by miR-155.
Microglia from miR-155flx/flx or mBIC-FSF mice were isolated, plated, and transfected with rAAV2-Cre for 7 days, then RNA was isolated and assayed by qPCR for changes in miRNA expression (unpaired t-test). (a) miR-155 CKO showed a significant decrease in miR-155 expression (p = .0048). (b) miR-155 OX showed a significant increase in miR-155 expression (p = .0335). These indicate that the virus is working as expected in microglia. Microglia were then treated with 1 μM fAβ1-42 for 6 hr. Lysosomal fAβ1-42 levels were detected using flow cytometry (BD LSRII). (c) Representative plots of fluorescence detected from each of the cell types analyzed. (d) We observed significant differences between all three conditions indicating that altering miR-155 expression changes microglia internalization and transit of fAβ1-42 to low pH compartments. One-way ANOVA (F (2,11)=76.19, p = .0001). Tukey's corrected multiple comparisons: Control v. miR-155 OX, p = .0001; miR-155 OX v. miR-155 CKO, p < .0001; Control v. miR-155 CKO: p = .0002. Key: **** = p < .001, *** = p < .01
FIGURE 6
FIGURE 6. Conditional manipulation of miR-155 expression impacts fAβ1-42 catabolism in low-pH compartments and internalization at the plasma membrane.
Microglia isolated from WT, miR-155 flx, or mBIC-FSF mice, plated, and infected with rAAV2-Cre for 7 days, then exposed to fAβ1-42 -pHrodo or fAβ1-42 −488 for 12, 18, and 24 hr. Total internalization and levels of fAβ1-42 located in low-pH compartments was detected using flow cytometry (BD LSRII). Geometric mean of biological replicates (n = 3) were analyzed. (a) Using a Two-Way ANOVA we observed an interaction of genotype and time (F (6,15) = 8.827, p = .0003) of miR-155 CKO and fAβ1-42 -pHrodo exposure over time. A significant shift to low-pH compartments was detected in miR-155 CKO microglia using fAβ1-42 -pHrodo at 6 hr compared to miR-155 OX microglia (Tukey's corrected multiple comparisons, p = .0001). (b) Using a two-way ANOVA we observed an interaction of genotype and time (F (6,18) = 4.752, p = .0046). Tukey's corrected multiple comparisons showed a significant increase in fAβ1-42-488 internalization relative to control by miR-155 CKO microglia (p = .0388) and miR-155 OX microglia (p = .0287) at 6 hr. miR-155 CKO microglia showed non-significant trends in fAβ1-42-488 internalization at 12 hr compared to control (p = .052) or miR-155 OX microglia (p = .2040). At 18 hr miR-155 CKO microglia peak in fAβ1-42-488 internalization compared to miR-155 OX microglia (p = .0214), with a plateau thereafter. Key: **** = p < .0001, * = p < .05

Similar articles

Cited by

References

    1. Alexandrov P, Zhai Y, Li W, & Lukiw W (2019). Lipopolysaccharide-stimulated, NF-kB-, miRNA-146a- and miRNA-155-mediated molecular-genetic communication between the human gastrointestinal tract microbiome and the brain. Folia Neuropathologica, 57(3), 211–219. 10.5114/fn.2019.88449 - DOI - PubMed
    1. Barrientos RM, Kitt MM, Watkins LR, & Maier SF (2015). Neuroinflammation in the normal aging hippocampus. Neuroscience, 309, 84–99. 10.1016/j.neuroscience.2015.03.007 - DOI - PMC - PubMed
    1. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, … Baltimore D. (2011). miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The Journal of Experimental Medicine, 208(6), 1189–1201. 10.1084/jem.20101823 - DOI - PMC - PubMed
    1. Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, … Weiner HL (2015). Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Annals of Neurology, 77(1), 75–99. 10.1002/ana.24304 Erratum in: Ann Neurol. 2015 Jun;77(6):1085. - DOI - PMC - PubMed
    1. Butovsky O, & Weiner HL (2018). Microglial signatures and their role in health and disease. Nature reviews. Neuroscience, 19(10), 622–635. 10.1038/s41583-018-0057-5 - DOI - PMC - PubMed

Publication types